Prof. Dr. V. Balaji MD.FRCP (Glasgow, London, Edinburgh), Fellowship in Diabetology (Sweden)

Prof. Dr. V. Balaji graduated from Kilpauk medical college and completed his Post graduation (M.D. General Medicine) from KMC, Manipal. Subsequently, he underwent Fellowship in Diabetology at the prestigious Karolinska Institute, Stockholm, Sweden.

He also completed advanced training in complications of Diabetes at the Steno Diabetes centre, Denmark.

He is also a Fellow of the Royal College of Physicians, Glasgow, Fellow of the Royal College of Physicians, Edinburgh and Fellow of the Royal College of Physicians, London.

Presently he is the Director and Senior Consultant Diabetologist at Dr. Balaji Diabetes Care Centre and Dr. Seshiah Diabetes Research Institute.

He has recently received the Vocational Excellence Award from The TN Dr. M. G. R. Medical University. He is the recipient of the International Diabetic Federation fellowship award in 1995.

Recognitions

  • Project Coordinator – World Diabetes Foundation – Gestational Diabetes Mellitus Project, Chennai – India
  • Project Coordinator – World Diabetes Foundation – Gestational Diabetes Mellitus Training Program, Chennai – India. (G.O. issued by The Health and Family Welfare Department, G.O. (D) No. 203, Health and Family Welfare (P1) Department, dt. 05-03-2008)
  • Project Head – World Diabetes Foundation – Gestational Diabetes Mellitus – Follow up of Mother and Child – 15 Years Study
  • Member of the World Health Organization Expert Committee for consultation on diagnosis and screening for gestational diabetes.
  • He is an Invited reviewer for the journal Diabetes Care of American Diabetes Association.
  • Task Force Committee member of the Indian Council of Medical Research (ICMR) on Pregnancy and Diabetes.
  • Founder secretary Diabetes and pregnancy study group India.
  • Reviewer of Diabetes Care – International Journal of American Diabetes Association
  • Indian representative as council Member – The International Association of Diabetes and Pregnancy Study groups (IADPSG).
  • Secretary General – South Asian Initiative for Diabetes In Pregnancy (SAIDIP)

Prof. Dr. V. Balaji MD.FRCP (Glasgow, London, Edinburgh), Fellowship in Diabetology (Sweden)

Qualifications

  • MBBS Kilpauk medical College, University of Madras 1989
  • MD (General medicine) Kasturba medical college, Manipal University of Mangalore 1993
  • Fellowship of the Royal College of Physicians, Glasgow 2008.
  • Fellowship of the Royal College of Physicians, Edinburgh 2010
  • Fellowship of the Royal College of Physicians, London 2012

Postgraduate Training

  • Fellowship in Diabetology Karolinska Institute, Stockholm Sweden, 1995
  • Advanced training in complication of Diabetes at Steno diabetes center Copenhagen, Denmark, 1999

Teaching experience

  • Faculty for FRCS teaching Programme Apollo Hospital.
  • Faculty for DNB (post graduation -general medicine) Apollo Hospital
  • Indian faculty ADA American Diabetes association post graduate course

Awards & Achievements

  • Awarded fellowship in Diabetology by International Diabetic Federation, 1995
  • Dr J C Patel and Dr B C Mehta Best Paper Award under the category of Original Research articles – Journal of Association of Physicians of India 2004.
  • Master oration Mayo clinic update, Mumbai 2006 – Gestational diabetes currents concepts, Indian scenario
  • Invited as Guest speaker Asia specific Diabetic meet organized by Hoechst Marrion Rousell, Barcelona 1998.
  • Delivered the Hoechst Gold Medal Oration at The Association of Physicians of India Conference, APICON 2009.
  • Project coordinator for Gestational Diabetes Screening in Tamil Nadu. This is a project by World Diabetes Foundation, recognized by the Government of Tamil Nadu. Based on this project, The Health and Family Welfare Department has issued an order, Letter (D) No.356 dated 14-03-2007, to make screening for diabetes in pregnant women mandatory.
  • Invited Guest speaker – International Diabetes Federation (IDF) – The International Association of the Diabetes and Pregnancy Study Groups (IADPSG), Montreal, Canada – October 2009
  • Delivered the Prof. Sam G P Moses Oration at the Research Society for the Study of Diabetes In India (RSSDI), Nov 2010, Kochi.
  • Delivered the prestigious “Dr. B R Sengupta Oration” at the 18th Annual Conference of API West Bengal held at Kolkata – September, 2011.

Research Fields

Social Service

  • Conducted Several Diabetic camps and Diabetic Awareness Education Programmes.
  • Have given several patient awareness programs on general health and diabetes in popular T V Shows.
  • Through the World Diabetes Foundation – Gestational Diabetes project has rendered free diagnosis and treatment for antennal women who had Gestational Diabetes mellitus.

Professional Affiliations Memberships

  • Indian Medical Association
  • Association of Physicians of India
  • Diabetic Association of India
  • European Diabetic Association
  • American Diabetes Association
  • RSSDI – Research society for the study of Diabetes in India
  • DIPSI- Diabetes and pregnancy study group India

Research Fields

  • Epidemiology of Gestational Diabetes.
  • Community based field work – Diagnosis, Awareness and prevention of Gestational Diabetes supported by World Diabetes Federation, WDF.
  • Prevalence of GAD antibodies in IGT
  • Genetic markers of young Diabetics
  • Insulin Analogs in Gestational Diabetes

As Principal investigator for the following International GCP trials

  • ORIGIN outcome reduction with initial glargine study
  • F3ZMC 10NM intervention study
  • DETEMIR Study
  • INFLABLOC StudyHIIP (pulmonary insulin) Study
  • DPP4 inhibitors
  • GLP 1 Analog in treatment of Diabetes
  • New anti-obesity drug
  • Exenatide study
  • Liraglutide study
  • AERx trial
  • LEADER Study
  • B1521004 Study
  • EDGE Study
  • DEGLUDEC Studies in Type 1 and Type 2

Books and Chapters

  • Co author, chapter of Pregnancy & Diabetes; Endocrinology, Metabolism and Diabetes-Research society for study of Diabetes in India.
  • Co-author, chapter of oral hypoglycemic agents, Prospective and realities- Novo Nordisk diabetes update`94
  • Co-author, chapter of Diabetic ketoacidosis – Novo Nordisk proceedings 1996
  • Co-author, chapter of Diet in IDDM – API (Association of physicians of India) update (proceedings) 1996
  • Author, Chapter of Gestational diabetes. API- Association of Physicians of India Textbook of medicine update 2002
  • Rising burden of Diabetes and its complications API medicine update vol II 2001 V.Seshiah,V. Balaji, Madhuri
  • Diabetic ketoacidosis V.Seshiah API textbook of medicine update 2001
  • Co- author, Handbook of Diabetes, edition II, III and IV, 2004, 2006, 2008
  • Co- authored chapter on Gestational Diabetes in developing countries, International text book of Diabetes and pregnancy

Publications in peer reviewed journals

  • Balaji V, M.Balaji, V.Seshiah, A.S.Shautttvre and C.B.Sanjeevi. Autoimmune diabetes constitutes significant proportion of patients diagnosed as gestational diabetes. Diabetologia 2000 43, suppl1 74 page A19.
  • Balaji V. Antibodies to TTGO Ab is not increased but GAD 65 and IA2 antibodies are increased in NIDDM patients from S. India. 17th IDF Congress Mexico Abstract book Nov. 2000
  • Balaji V, M.Balaji, V.Seshiah, C.B.Sanjeevi, A.Shtauvere. Ann. N.Y. Acad. Sci 958:281-284 (2002). Women diagnosed as GDM do not carry antibodies against minor islet cell antigens.
  • Balaji V, V.Seshiah, Madhuri S Balaji, C B Sanjeevi, Anders Green.  Gestational Diabetes Mellitus in India. Journal of The Association of Physicians of  India September 2004;52:707.
  • Balaji V, V Seshiah, Madhuri S Balaji , Aruna Sekar, C B Sanjeevi, Anders Green.One step procedure for screening and diagnosis of gestational diabetes mellitus, J Obstet Gynecol Ind. Vol.55, 6: November/December 2005 Pg 525-529
  • Balaji V, Balaji MS, Seshiah V, Mukundan S, Datta M. Maternal glycemia and neonates birth weight in Asian Indian women. Diabetes Res Clin Pract. 73  (2006) 223-224.
  • Balaji V, Madhuri S Balaji.Glycemic Control from Early Weeks of Gestation and Pregnancy Outcome. Seshiah V, Cynthia Alexander, 66th Scientific Session of ADA, Washington 2006, Diabetes. 2006 June; 55 (suppl 1): A 604
  • Balaji V, V.Seshiah, Madhuri S Balaji, Panneerselvam A, Early Screening for Gestational Diabetes. 66th Scientific Session of ADA, Washington 2006, Diabetes. 2006 June; 55 (suppl 1): A 606
  • Balaji V, Anjalakshi C, Balaji MS, Seshiah V A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women., Diabetes Res Clin Pract. 2006 Nov 16;
  • Balaji V, Seshiah V, Joshi SR, Parikh MN, Gupta Gestational diabetes mellitus—guidelines. Diabetes in Pregnancy Study Group.. J Assoc Physicians India. Das AK, S; 2006 Aug;54:622-8.
  • Balaji V, S Madhuri Balaji, A Panneerselvam, S Ashalata, V Seshiah. Glycemic Level at The First Visit Likely To Predict Gestational Diabetes Mellitus. 4th International Symposium on Diabetes and Pregnancy March 29 – 31, 2006-Istanbul, Turkey.
  • Balaji V, Madhuri S Balaji, Cynthia Alexander, S Ashalata, Sheela Suganthi, V Seshiah. Novomix – Mixture of Insulin Aspart and Protamine Crystallized Insulin Aspart In Gestational Diabetes Mellitus. 4th International Symposium on Diabetes and Pregnancy  March 29 – 31, 2007-Istanbul, Turkey.
  • Balaji V, V Seshiah, Madhuri S Balaji, S Ashalata. Insulin levels in GDM and NDT women. Diabetes Vol 56: Suppl 1; June 2007, A 663.
  • Balaji V, V Seshiah, Madhuri S Balaji, Sheela Suganthi. Adiponectin Levels in Pregnancy. Diabetes Vol 56: Suppl 1; June 2007, A 707.
  • Balaji V, Madhuri BS, Ashalatha S, Sheela S, Suresh S, Seshiah V. A1C in gestational diabetes mellitus in Asian Indian women. Diabetes Care. 2007 Jul;30(7):1865-7.
  • Balaji V, Seshiah V, Balaji MS, Paneerselvam A, Arthi T, Thamizharasi M, Datta M Gestational diabetes mellitus manifests in all trimesters of pregnancy..Diabetes Res Clin Pract. 2007 Sep;77(3):482-4.
  • Balaji V, Madhuri S Balaji, Ashalatha S, Seshiah V.Insulin Secretory Pattern In Normal Glucose Tolerant & Gestational Diabetic Women And Fetal Outcome. 39th Annual DPSG meeting, Ibiza, Spain, Sept 21 – 24, 2007
  • Balaji V, Seshiah V, Insulin therapy during pregnancy. J Assoc Physicians India. 2007 Jul;55 Suppl:44-6.
  • Balaji V, Seshiah V, Balaji MS, Panneerselvam A, Arthi T Glycemic level at the first visit and prediction of GDM,. J Assoc Physicians India. 2007 Sep;55:630-2.
  • Balaji V, Seshiah V, Madhuri S Balaji. Scope for Prevention of Diabetes-‘Focus intrauterine millieuinterieur’.JAPI.2008.Feb;56.Suppl:109-13.
  • Balaji V, Seshiah V, Balaji MS, Panneerselvam A, Manjula Datta, , Arthi T . Prevalence of Gestational Diabetes Mellitus in South India (Tamil Nadu) – A community based study,  J Assoc Physicians India. 2008 May; 56: 329-33
  • Balaji V, Seshiah V, Cynthia A, Balaji MS, Ashalata S, Sheela R, , Arthi T. Detection and care of women with gestational diabetes mellitus from early weeks of pregnancy results in birth weight of newborn babies appropriate for gestational age. Diabetes Res Clin Pract. 2008 May; 80(2):199-202.
  • Balaji V, Seshiah V, Anjalakshi C, Madhuri S Balaji,  Ashalatha S, Sheela Suganthi, Arthi T. Glycemic Excursions In Indian Pregnant Women Monitored By Continuous Glucose Monitoring System- A Pilot Study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2008 September; 2 (3): 179-184.
  • Balaji V, Seshiah V, A. Paneerselvam, Madhuri S Balaji. “Abnormal” Fasting Plasma Glucose during Pregnancy. Diabetes Care.  2008 Dec;31(12):e92.
  • Balaji V, Anjalakshi C, Madhuri S Balaji , Ashalata S, Sheela Suganthi, Arthi T, Thamizharasi M, Seshiah V.A Single Test Procedure to Diagnose Gestational Diabetes Mellitus. Acta Diabetologica 2009 Mar;46(1):51-4.
  • Balaji V, Seshiah V,.Insulin Analogue Therapy in Pregnancy with Diabetes.  J Assoc Physicians  India 2009 Feb; 57 Suppl : 34-7.
  • Balaji V, Seshiah V, Balaji MS, Paneerselvam A, Kapur A.Pregnancy and diabetes scenario around the world: India. Int J Gynaecol Obstet. 2009 Mar;104 Suppl 1:S35-8.
  • Balaji V, Seshiah V,. Detection and care of women with GDM. International Diabetes .Monitor 2009 June;21(3): 121-3.
  • Balaji V, Seshiah V, Sahay BK, Das AK, Siddharth Shah, Samar Banerjee, Rao PV, Ammini A,  Sunil Gupta, Hema Divakar, Sujata Misra, Uday Thanawala. GESTATIONAL DIABETES MELLITUS – Indian Guidelines, Journal of the Indian Medical Association Vol 107; No. 11: Nov 2009: 799.
  • Balaji V, Madhuri Balaji, Cynthia Alexander, Ashalata S, Sheela Suganthi, Suresh S, Seshiah V.  Premixed Insulin Aspart 30 (Biasp 30) Vs Premixed Human Insulin 30 (BHI 30) In Gestational Diabetes Mellitus – A Pilot Study”. J Assoc Physicians India 2010 Feb; 58: 95-97.
  • Balaji V, Seshiah V,. Diabetes in Pregnancy Study Group. Fifth National Conference of Diabetes in Pregnancy Study Group, India. J Assoc Physicians India. 2010 May;58:329-30.
  • Balaji V, Mohan V, Jain S, Kalra S, Mittal A.Liraglutide: Bench to Bedside. J Assoc Physicians India 2010 June (suppl); 58: 15-17.
  • Balaji V, Seshiah V. Management of Diabetes in Pregnancy. J Assoc Physicians India. April 2011. Vol. 59: 33-36.
  • Balaji V, Madhuri Balaji, Anjalakshi C, Cynthia A, Arthi T, Seshaih V.Diagnosis of gestational diabetes mellitus in Asian-Indian women. Indian Journal of Endocrinology and Metabolism. Jul-Sep 2011. Vol.15(3): 187-190.
  • Balaji V, Madhuri Balaji, Anjalakshi C, Cynthia A, Arthi T, Seshiah V.Inadequacy of Fasting Plasma Glucose to Diagnose Gestational Diabetes Mellitus in Asian Indian Women. Diabetes Res Clin Pract. 2011 Oct;94(1):e21-3.
  • Balaji V, Madhuri BS, Paneerselvam A, Arthi T, Seshiah V. Comparison of venous plasma glucose and capillary whole blood glucose in the diagnosis of gestational diabetes mellitus: a community-based study. Diabetes Technol Ther. 2012 Feb;14(2):131-4.
  • Balaji V, Balaji MS, Alexander C, Ashlata S, Suganthi Sheela R, Arthi T, Seshiah V. Premixed Insulin Aspart 30 (Biasp 30) Vs Premixed Human Insulin 30 (BHI 30) In Gestational Diabetes Mellitus – A randomized Controlled Study. Gynecol Endocrinol, 2012 Apr 3 (Epub ahead of print).
  • Balaji V,  Anjalakshi C,  Amitha I,  Madhuri S Balaji, Seshiah V Safety And Efficacy Of Acarbose – An Alpha Glucose Inhibitor In The Management Of Gestational Diabetes Mellitus (GDM)  – A Pilot Study.
  • Balaji V, Madhuri BS, Paneerselvam A, Arthi T, Seshiah V.Point of Care for Gestational Diabetes Mellitus – A community based study.  Journal of Indian Medical Association.
  • Balaji V, Veeraswamy Seshiah. Gestational diabetes: The public health relevance and approach., Gupta VK, Kapur Anil.Diabetes Res Clin Pract. 2012 Jun 20. [Epub ahead of print]
  • Balaji V, Seshiah V, Siddharth Shah, Shashank Joshi, AK Das, Sahay BK, Samar Banerjee, Zargar AH, Madhuri Balaji. Diagnosis of gestational diabetes in the community. J Assoc of Phy India, August  2012, Vol – 60
  • Balaji V, Balaji MS, Alexander C, Srinivasan A, Suganthi SR, Thiyagarajah A, Seshiah V.Premixed insulin aspart 30 (BIAsp 30) Vs premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study. Gynecologicaly Endocrinology. 2012 Jul;28(7):529-32. doi: 10.3109/09513590.2011.650661. Epub 2012 Apr 3
  • Balaji V, Seshiah Veeraswamy, Vitull K Gupta, Anil Kapur. Gestational Diabetes: The Public health relevance and approach. Diabetes Res Clin Pract. 2012 Sep;97(3):350-8. doi: 10.1016/j.diabres.2012.04.024. Epub 2012 Jun 21.
  • Balaji V, Sanjay Kalra, C. R. A. Moses, V. Seshiah, B. K. Sahay, A. Kumar, A. J. Asirvatham, A. K. Das, S. Akhtar, R. Shetty.Physician’ perceptions of a national consensus guideline on insulin therapy: Data from the impact study. Indian J Endocr Metab. 2012;16(2):426-7. Doi: 10.4103/2230-8210.104117.
  • Balaji V, Ashok Kumar Das, V. Seshiah, B. K. Sahay, A. Kumar, A. J. Asirvatham, S. Kalra, R. Channabasavaiah, R. Shetty, C. R. A. Moses.Improving management  practices and clinical outcomes in type 2 diabetes study: Prevalence of complications in people with type 2 diabetes in India.  Indian J Endocr Metab. 2012 ;16(2):S430-1. Doi: 10.4103/2230-8210.104119.
  • Balaji V, C. R. Anand Moses, V. Seshiah, B. K. Sahay, A. Kumar, A. J. Asirvatham, , S. Kalra, S. Akhtar, R. Shetty, A. Kumar Das.Baseline results indicate poor glycemic control and delay in initiation and optimization of insulin therapy: results from the improving management practices and clinical outcomes in type 2 diabetes study. Indian J Endocr Metab. 2012 ;16(2):432-3. Doi: 10.4103/2230-8210.104120.
  • Balaji V, Veeraswamy Seshiah, Ashalatha Srinivasan, Madhuri S. Balaji, Arthi Thiyagarajah.Comparison of Glycated Albumin (GA) and Glycosylated Hemoglobin (A1C) in monitoring glycemic excursions during pregnancy. Open Journal of Obstetrics and Gynecology, 2013, 3, 47-50. doi:10.4236/ojog.2013.31011, published Online January 09, 2013.
  • Balaji V & Veerasamy Seshiah. Primordial prevention: maternal health and diabetes.. Diabetes Manage.  2013;3(4),333–341. 10.2217/DMT.13.24.
  • Balaji V. Efficacy and safety of pioglitazone in type 2diabetes in the Indian patients: Results of an observational study. Indian J Endocr Metab 2013;17:709-15. Doi:10.410/2230-8210.113766.
  • Balaji V, Seshiah V, Kalra S, Gupte S, Divakar H, Murugananthan A, Banerjee S, Gupta S, , Zargar A, Das A, Sahay R, Singh J, Sadikot S, Khadgawat R.  Classification of Hyperglycemia In Pregnancy. Indian J Endocrinol Metab. 2014 Jul;18(4):445-8. doi: 10.4103/2230-8210.137484
  • Balaji V, Balaji MS, Datta M, Rajendran R, Nielsen K, Radhakrishnan R, Kapur A, Seshiah V. A cohort study of gestational diabetes mellitus and complimentary qualitative research: background, aims and design. BMC Pregnancy Childbirth. 2014 Nov 25;14(1):378
  • Balaji V, Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E,Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR;  Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8.
  • Balaji V, Veeraswamy S, Divakar H, Gupte S, Datta M, Kapur A,Need for testing glucose tolerance in the early weeks of pregnancy. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):43-6. doi: 10.4103/2230-8210.172238.
  • Balaji V, Kragelund Nielsen K, Damm P, Kapur A, Balaji MS, Seshiah V, Bygbjerg IC. Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India. PLoS One. 2016 Mar 18;11(3):e0151311. doi: 10.1371/journal.pone.0151311. eCollection 2016.

Research paper Presentations in National and International congress

  • Efficacy of D400 in treatment of NIDDM. International Diabetic Federation congress, Helsinki, June 1997
  • Is type 2 Diabetes prevention feasible and realistic in Asia. First Asia pacific Diabetes experts meet , Barcelona 1998.
  • Insulin Kinetics to clinical practice-API-2000
  • GAD antibodies in GDM- EASD Jerusalem 2001,RSSDI, Research society for study of Diabetes in India, Cuttack 2000
  • Autoimmune diabetes constitutes significant proportion of patients diagnosed as gestational diabetes. EASD Jerusalem 2001
  • Antibodies to TTGO Ab is not increased but GAD 65 and IA2 antibodies are increased in NIDDM patients from S. India. 17th IDF Congress Mexico Nov. 2000
  • Relevance and implications of impaired glucose tolerance as an entity V.Seshiah, V.Balaji RSSDI proceedings 1998, Bombay.
  • Prevalence of IGT in GDM Lilly update, Bangkok 2002
  • MIC A gene in GDM, A. Shauvtere, Sanjeevi C.B, Balaji .V, Balaji M., International congress of immunological society for diabetes – Chennai 2001 Feb.
  • Gestational diabetes – current concepts revisited, NNDU update Colombo 2003
  • Frequency of Glucose Intolerance during pregnancy in Indian women and its legacy, IDF Congress, Aug 2003 Paris.
  • Correlation Between Maternal Glycemic Levels And Birth Weight In Asian Indians. 35th Annual Meeting of the Diabetes and Pregnancy Study Group, Luso, Portugal September, 2004.
  • One step procedure for screening and diagnosis of gestational diabetes mellitus’ 35th Annual Meeting of the Diabetes and Pregnancy Study Group being held at Luso, Portugal, September, 2004.
  • Insulin Aspart – Safe During Pregnancy. Dr V Seshiah, Dr V Balaji, Dr Madhuri S Balaji, 65th Scientific Session ADA, San Diego 2005
  • Insulin Aspart – Safe During Pregnancy. Dr V Seshiah, Dr V Balaji, Dr Madhuri S Balaji, 37th Annual Meeting of the Diabetes and Pregnancy Study Group, Myconos, Greece 2005
  • Prevalence of GDM in Asian Indians – A Community Based Study. V.Seshiah, V.Balaji, Madhuri S Balaji, 5th International Workshop Conference on Gestational Diabetes, Nov 2005, Chicago
  • Novomix – Mixture of Insulin Aspart and Protamine Crystallized Insulin Aspart in Gestational Diabetes Mellitus, 4th International Symposium on Diabetes and Pregnancy. March 29 – 31, 2007-Istanbul
  • Use of Novomix in Pregnancy, Diabetes in Pregnancy study Group of India, DIPSI, 2008.
  • Gestational Diabetes Mellitus – Translating Research to Clinical Practice, HOECHST SENIOR LECTURESHIP IN DIABETES – API 2009
  • Monitoring glycemic control and Insulin Analogues in pregnancy, DIPSI 2009
  • Premixed Insulin Aspart 30 (BIAsp 30) Vs Premixed Human Insulin 30 (BHI 30) in Gestational Diabetes Mellitus- A Pilot Study, 5th International Symposium on Diabetes and pregnancy, March 26-28, 2009, Sorrento, Italy.
  • International Diabetes Federation Diabetes in Pregnancy Guidelines – The Indian perspective & Implications of Worldwide Implementation of Diagnostic Criteria for GDM at the 2009 CDA Canadian Diabetes in Pregnancy Study (CanDIPS) Group Meeting in association with the International Association for Diabetes in Pregnancy Study Group, Montreal, Oct 2009.
  • TRANSLATING EVIDENCES INTO POLICY – EXPERIENCES FROM INDIA. The 6th International Symposium on Diabetes and Pregnancy, March 23-26, 2011, Salzburg, Austria.

Course and updates – National & International

1. Continuing Medical Education Programme-Kasturba Medical College, Manipal 1992.

2. 8th National Diabetes Congress, Calcutta, October 1993.

3. National Diabetes update Novo Nordisk, Madras January 1994.

4. National Eli-Lilly-Ranbaxy update, April 1994.

5. National Diabetes Update Novo Nordisk Feb 1995.

6. APICON 1995, Chennai

7. National Diabetes Update Novo Nordisk Feb 1996.

8. APICON 1996, Kathmandu

9. APICON 1997, KGMC

10. National Diabetes Update Novo Nordisk Feb 1997.

11. Research Society for study of Diabetes in India, 1997.

12. Research Society for study of Diabetes in India, 1998.

13. Lilly National Diabetes Update 1998.

14. National Diabetes Update Novo Nordisk Feb 1998.

15. APICON 1998, Bangalore

16. National Diabetes Update, Novo Nordisk, Feb 1999

17. Research Society for study of Diabetes in India, 1999

18. APICON 1999, Kolkata

19. National diabetes update Novo Nordisk, Feb 2000

20. APICON 2000, Jaipur

21. Annual Scientific Meeting of Research Society for study of Diabetes in India, Mumbai, 2000

22. National diabetes update Novo Nordisk, Feb 2001 Chennai

23. Annual Scientific Meeting of Research Society for study of Diabetes in India, Mumbai, 2000

24. APICON 2001, New Delhi

25. Annual Scientific Meeting of Research Society for study of Diabetes in India, Chandigarh, 2001

26. National diabetes update Novo Nordisk, 2002 Delhi

27. Annual Scientific Meeting of Research Society for study of Diabetes in India, Kochi, 2002

28. APICON 2003, Varanasi

29. Annual Scientific Meeting of Research Society for study of Diabetes in India, Jaipur, 2003

30. APICON 2004, Hyderabad

31. Annual Scientific Meeting of Research Society for study of Diabetes in India, Patna, 2004

32. APICON 2005, Mumbai

33. Annual Scientific Meeting of Research Society for study of Diabetes in India, Bangalore, 2005

34. APICON 2006, Patna

35. Annual Scientific Meeting of Research Society for study of Diabetes in India, New Delhi, 2006

36. APICON 2007, Goa

37. Annual Scientific Meeting of Research Society for study of Diabetes in India, Kolkata, 2007

38. APICON 2008, Kochi

39. Annual Scientific Meeting of Research Society for study of Diabetes in India, Hyderabad, 2008

40. APICON 2009, New Delhi

41. Annual Scientific Meeting of Research Society for study of Diabetes in India, Ahmedabad, Nov 2009

42. UPDACON, Aligarh, Nov 2009.

43. APICON, Jaipur, Jan 2010

44. AICOG, Guwahati, Jan 2010

45. GDM Workshop, Goa, Feb 2010

46. ISD 2010, March 2010

47. DIABCON, New Delhi, April 2010

48. Regional Diabetes India update, Ahmedabad, Aug 2010

49. 27TH Annual Conference of the Obstetric and Gynecological Society of Southern India, Chennai, Nov 2010

50. RSSDI 2010, Kochi

51. 4th National Insulin Summit, Dec 2010, Puduchery

52. APICON 2011, Ahmedabad

53. DIABCON2011, New Delhi

54. 4th Diabetes India International Conference, April 2011, New Delhi

55. 18th Annual Conference of API West Bengal, September 2011, Kolkata

56. TAPICON, April 2012, Chennai.

57. International Diabetes Federation- world congress (KOBE) Japan nov 1994

58. International Diabetes Federation-World Congress, Helsinki, July 1997.

59. EASD-European Association for study of Diabetes, Barcelona, Sept 1998

60. EASD-Brussels 1999

61. ADA-San Diego 1999.

62. IDF-Asia Pacific Congress Sydney-1999.

63. EASD 2000 Jerusalem

64. ADA 2000 San Francisco

65. Eli Lilly diabetes update 2000, Malaysia

66. ADA 2001 Philadelphia

67. EASD 2001 Glasgow

68. Eli Lilly diabetes update 2001, Dubai

69. ADA 2002 San Francisco

70. EASD 2002 Budapest

71. Eli Lilly diabetes update 2002, Bangkok

72. National diabetes update Novo Nordisk 2003 Colombo

73. ADA 2003 New Orleans

74. IDF Congress 2003 Paris, France

75. International Colloquium on Diabetes In Pregnancy, Chennai 2004

76. ADA 2004, Orlando, Florida

77. Annual Meeting of the Diabetes and Pregnancy Study Group 2004, Luso – Portugal

78. EASD 2004 Munich, Germany

79. National Diabetes Update Novo Nordisk, Feb 2005 Kuala Lumpur

80. ADA 2005, Sandiego, California

81. EASD 2005, Athens, Greece

82. Annual Meeting of the Diabetes and Pregnancy Study Group 2005, Myconos, Greece

83. 5th International Workshop on Gestational Diabetes, Nov 2005, Chicago

84. National Diabetes Update Novo Nordisk, Feb 2006 Bangkok

85. Diabetes In Pregnancy Study Group India – DIPSI, Feb 2006, Chennai

86. Lilly diabetes update Singapore Aug 2006

87. 2nd National Conference of Diabetes In Pregnancy Study Group India (DIPSI), Feb 2007

88. Diabetes In Pregnancy Study Group India – DIPSI, Feb 2007, Hyderabad

89. 4th International Symposium on Diabetes and Pregnancy, Istanbul, March 29-31, 2007

90. ADA 2007, Chicago.

91. Diabetes in Pregnancy Study Group India- DIPSI, Feb 2008, Nagpur.

92. Global Alliance for Women’s Health Expert Meeting at UN Headquarters, April 2008.

93. ADA 2008, San Francisco

94. IADPSG 2008, Pasadena

95. EASD 2008, Rome.

96. Diabetes In Pregnancy Study Group India – DIPSI, Feb 2009, Chennai

97. 5th International Symposium on Diabetes and Pregnancy, Sorrento, Italy March 26-28, 2009

98. ADA June 2009, New Orleans

99. 20th World Diabetes Congress – IDF, Montreal, Canada, Oct 2009

100. 2009 CDA Canadian Diabetes in Pregnancy Study (CanDIPS) Group Meeting in association with the International Association for Diabetes in Pregnancy Study Group [IADPSG], Montreal, Oct 2009.

101. Diabetes In Pregnancy Study Group India – DIPSI, Feb 2010, Kolkata

102. GDM Pasadena II Scientific Meeting, April 2010, Pasadena, California

103. ADA June 2010, Orlando

104. EASD 2010, Stockholm

105. WHO Expert Committee meeting 2010, Geneva

106. Diabetes In Pregnancy Study Group India – DIPSI, Feb 2011, Mumbai

107. 6th International Symposium on Diabetes and Pregnancy – March 2011, Salzburg, Austria.

108. ADA 2011, San Diego, CA

109. International Association of Diabetes and Pregnancy Study Groups Conference, Feb 2012, Chennai